These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2745328)

  • 1. Importance of vasoconstriction in lipid mediator-induced pulmonary edema.
    Sakai A; Chang SW; Voelkel NF
    J Appl Physiol (1985); 1989 Jun; 66(6):2667-74. PubMed ID: 2745328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAF potentiates protamine-induced lung edema: role of pulmonary venoconstriction.
    Chen CR; Voelkel NF; Chang SW
    J Appl Physiol (1985); 1990 Mar; 68(3):1059-68. PubMed ID: 2341334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of platelet activating factor in the pulmonary circulation: an investigation using a novel isotopic system in rabbit isolated lung.
    Seale JP; Nourshargh S; Hellewell PG; Williams TJ
    Br J Pharmacol; 1991 Sep; 104(1):251-7. PubMed ID: 1786514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung endothelial and epithelial permeability after platelet-activating factor.
    Bolin RW; Martin TR; Albert RK
    J Appl Physiol (1985); 1987 Nov; 63(5):1770-5. PubMed ID: 3693212
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Cui X; Xu W; Neupane P; Weiser-Schlesinger A; Weng R; Pockros B; Li Y; Moayeri M; Leppla SH; Fitz Y; Eichacker PQ
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1076-H1090. PubMed ID: 30767685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of leukotriene C4 in pulmonary hypertension: platelet-activating factor vs. hypoxia.
    Davidson D; Singh M; Wallace GF
    J Appl Physiol (1985); 1990 Apr; 68(4):1628-33. PubMed ID: 2112129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary vascular reactivity: effect of PAF and PAF antagonists.
    Chen CR; Voelkel NF; Chang SW
    J Appl Physiol (1985); 1992 Nov; 73(5):1762-9. PubMed ID: 1474049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-activating factor potentiates protamine-induced lung edema. Role of eicosanoids.
    Chen CR; Voelkel NF; Chang SW
    Am J Respir Crit Care Med; 1994 Jan; 149(1):34-40. PubMed ID: 8111595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinolines attenuate PAF-induced pulmonary pressor responses and edema formation.
    Falk S; Göggel R; Heydasch U; Brasch F; Müller KM; Wendel A; Uhlig S
    Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1734-42. PubMed ID: 10556149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged pulmonary hypertension caused by platelet-activating factor and leukotriene C4 in the rat lung.
    Davidson D; Drafta D
    J Appl Physiol (1985); 1992 Sep; 73(3):955-61. PubMed ID: 1400062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FMLP causes eicosanoid-dependent vasoconstriction and edema in lungs from endotoxin-primed rats.
    Voelkel NF; Czartolomna J; Simpson J; Murphy RC
    Am Rev Respir Dis; 1992 Mar; 145(3):701-11. PubMed ID: 1546853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAF increases capillary pressure but not vascular permeability in isolated blood-perfused canine lungs.
    Shibamoto T; Yamaguchi Y; Hayashi T; Saeki Y; Kawamoto M; Koyama S
    Am J Physiol; 1993 May; 264(5 Pt 2):H1454-9. PubMed ID: 8498559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of platelet activating factor on vascular responsiveness in isolated rat lungs.
    Gillespie MN; Bowdy BD
    J Pharmacol Exp Ther; 1986 Feb; 236(2):396-402. PubMed ID: 3944767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary vascular injury by polycations in perfused rat lungs.
    Chang SW; Westcott JY; Henson JE; Voelkel NF
    J Appl Physiol (1985); 1987 May; 62(5):1932-43. PubMed ID: 2885303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukotrienes C4 and D4 do not increase filtration coefficient of excised perfused guinea pig lungs.
    Albert RK; Greenberg G; Guest RJ; Luchtel D; Henderson WR
    J Appl Physiol (1985); 1987 Jan; 62(1):1-9. PubMed ID: 3558172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of peptidoleukotriene-induced increases in pulmonary transvascular fluid filtration.
    Noonan TC; Selig WM; Kern DF; Malik SB
    J Appl Physiol (1985); 1986 Nov; 61(5):1928-34. PubMed ID: 3781998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxygen-radical-mediated permeability edema and vasoconstriction in isolated perfused rabbit lungs.
    Tate RM; Vanbenthuysen KM; Shasby DM; McMurtry IF; Repine JE
    Am Rev Respir Dis; 1982 Nov; 126(5):802-6. PubMed ID: 7149444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary hypertension and edema induced by platelet-activating factor in isolated, perfused rat lungs are blocked by BN52021.
    Imai T; Vercellotti GM; Moldow CF; Jacob HS; Weir EK
    J Lab Clin Med; 1988 Feb; 111(2):211-7. PubMed ID: 3339274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-2 induces pulmonary edema and vasoconstriction independent of circulating lymphocytes.
    Ferro TJ; Johnson A; Everitt J; Malik AB
    J Immunol; 1989 Mar; 142(6):1916-21. PubMed ID: 2784141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-activating factor increases lung vascular permeability to protein.
    Burhop KE; Garcia JG; Selig WM; Lo SK; van der Zee H; Kaplan JE; Malik AB
    J Appl Physiol (1985); 1986 Dec; 61(6):2210-7. PubMed ID: 3804927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.